Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    Pfizer: Off-label promotion of Bextra, Geodon, Zyvox and Lyrica, September 2009. In what was the largest pharmaceutical settlement in U.S. history at the time, Pfizer reached a $2.3 billion settlement with the Department of Justice to resolve criminal charges and civil claims under the False Claims Act.

  3. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon Inc. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]

  4. Pharmacy Out of Ozempic? Here's Exactly What To Do - AOL

    www.aol.com/pharmacy-ozempic-heres-exactly...

    If you miss a dose of your weight loss meds due to the shortage, don't panic. "If patients are not able to take the drugs immediately, they should be OK for another seven to 10 days," Dr ...

  5. Nepafenac - Wikipedia

    en.wikipedia.org/wiki/Nepafenac

    Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. [3] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX-2 ...

  6. US charges 193 people in $2.75 billion health care fraud bust

    www.aol.com/news/us-charges-193-people-2...

    June 27, 2024 at 3:52 PM. (Reuters) -The U.S. Justice Department has criminally charged 193 people, including 76 doctors, nurses and other medical professionals, with participating in health care ...

  7. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  8. Novartis to Spin-Off Alcon as Separate Trading Company - AOL

    www.aol.com/news/novartis-spin-off-alcon...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Novartis Obtains Final Shares of Alcon for $12.9 Billion - AOL

    www.aol.com/news/2010-12-15-novartis-obtains...

    Shares of Novartis (NVS) soared higher on Wednesday, after the Swiss drug maker finally obtained the remaining outstanding shares of Alcon (ACL) for $12.9 billion. Novartis had been trying to gain ...